Remyelination varies between and within lesions in multiple sclerosis following bexarotene. (2022)
Attributed to:
Dementias Platform UK Stem Cell Partnership
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/acn3.51662
PubMed Identifier: 36116011
Publication URI: http://europepmc.org/abstract/MED/36116011
Type: Journal Article/Review
Volume: 9
Parent Publication: Annals of clinical and translational neurology
Issue: 10
ISSN: 2328-9503